Skip to main content
All lobbying firms

McKesson Corporation & Its Affiliate U.S. Oncology

McKesson Corporation & Its Affiliate U.S. Oncology has made 7 Lobbying Disclosure Act filings for 1 client since 2025, reporting $5,390,000 of in-house lobbying expenses; the newest was posted October 20, 2026.

As filed: MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY.

$0 Income reported
1 Clients represented
7 Filings counted
0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. It also reported $5,390,000 of in-house lobbying expenses, which is what a registrant files when it lobbies for itself. 1 filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the registrant's LDA id (24566), not by name. Filings under this id have also been reported as MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP).

 Clients 1
 Lobbyists named 2
  • BRIAN BRANTON 8 filings · through 2026 Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative…
  • SHANA BEAVIN 1 filing · through 2026 Prof. Staff Member, House Energy & Commerce Committee Minority Staff; Program Analyst, Centers for Disease Control and Prevention; Leg. Dir., Rep. Jim Matheson.

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

 Reported by year 2 years
  • 2026 $2,000,000 3 filings
  • 2025 $3,390,000 4 filings
 Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 7
  • Health & Human Services, Dept of (HHS) 7
  • HOUSE OF REPRESENTATIVES 7
  • SENATE 7
  • Centers For Medicare and Medicaid Services (CMS) 6
  • White House Office 6
  • Office of Management & Budget (OMB) 2
  • Executive Office of the President (EOP) 1
 Recent filings 8 total
Q3 report
McKesson Corporation & Its Affiliate U.S. Oncology
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $610,000 expenses · posted Oct 20, 2026
View →
Q2 report
McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $530,000 expenses · posted Jul 20, 2026
View →
Q1 report
McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $860,000 expenses · posted Apr 20, 2026
View →
Q4 report
McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $1,180,000 expenses · posted Jan 19, 2026
View →
Q3 report
McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $530,000 expenses · posted Oct 20, 2025
View →
Q2 report
McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $460,000 expenses · posted Jul 17, 2025
View →
Q1 amendment
McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $1,220,000 expenses · posted Apr 24, 2025
View →
Q1 report
McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions Amended
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $1,220,000 expenses · posted Apr 21, 2025
View →

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem